Vir Biotechnology (VIR) Other Non Operating Income (2018 - 2026)
Vir Biotechnology (VIR) reported Other Non Operating Income of -$254000.0 for Q1 2026, down 252.78% on a YoY basis from $166254.5 in Q1 2025, and up 24.18% sequentially from -$335000.0 in Q4 2025.
Vir Biotechnology (VIR) Other Non Operating Income (2018 - 2026) Analysis & Trends
Vir Biotechnology (VIR) has 9 years of Other Non Operating Income data on file, last reported at -$254000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 252.78% year-over-year to -$254000.0; the trailing twelve-month figure through Mar 2026 stood at -$591000.0 (up 70.54% YoY), and the FY2025 full-year result was -$409000.0, up 81.58% from the prior year.
- Other Non Operating Income rose to -$254000.0 in Q1 2026, from -$335000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $27.0 million in Q3 2022 to a low of -$26.2 million in Q4 2022.
- A 5-year average of -$447941.2 and a median of -$287000.0 in 2024 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 42128.12% in 2022, while the deepest fall reached 374000.0% in 2022.
- Tracing VIR's Other Non Operating Income over 5 years: stood at -$26.2 million in 2022, then soared by 94.33% to -$1.5 million in 2023, then soared by 65.93% to -$506000.0 in 2024, then jumped by 33.79% to -$335000.0 in 2025, then increased by 24.18% to -$254000.0 in 2026.
- Business Quant data shows VIR's Other Non Operating Income at -$254000.0 in Q1 2026, -$335000.0 in Q4 2025, and -$228000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vir Biotechnology | 1.38 Bn | 1.38 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -254,000.00 |
| Dec 31, 2025 | -335,000.00 |
| Sep 30, 2025 | -228,000.00 |
| Jun 30, 2025 | 226,000.00 |
| Mar 31, 2025 | -72,000.00 |
| Dec 31, 2024 | -506,000.00 |
| Sep 30, 2024 | -893,000.00 |
| Jun 30, 2024 | -535,000.00 |
| Mar 31, 2024 | -287,000.00 |
| Dec 31, 2023 | -1.49 Mn |
| Sep 30, 2023 | 882,000.00 |
| Jun 30, 2023 | -367,000.00 |
| Mar 31, 2023 | -8.02 Mn |
| Dec 31, 2022 | -26.19 Mn |
| Sep 30, 2022 | 27.03 Mn |
| Jun 30, 2022 | 691,000.00 |
| Mar 31, 2022 | 2.73 Mn |
| Dec 31, 2021 | -7,000.00 |
| Sep 30, 2021 | 64,000.00 |
| Jun 30, 2021 | 752,000.00 |